Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-052755

Odonate Therapeutics, Inc. · ODT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Officer — Chief Executive Officer · Director · 10% Owner
John G Lemkey
Officer — Chief Financial Officer
Period of report
Sep 27, 2018
Accepted (ET)
Oct 1, 2018 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Sep 27, 2018P6,199$18.7013A12,628,537IBy LP
Common StockF3,F2Sep 28, 2018P3,801$18.9456A12,632,338IBy LP
Common StockF4,F2Sep 28, 2018P10,000$19.1722A12,642,338IBy LP
Common StockF5,F2Sep 28, 2018P20,000$19.3322A12,662,338IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses